Contents

CNS & Neurological Disorders - Drug Targets , Volume 8 - Number 2

Editorial [Hot Topic: Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part II (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

, 8(2): 82 - 87

David H. Cribbs and Michael G. Agadjanyan


DOI: 10.2174/187152709787847270




Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial

, 8(2): 88 - 97

Tyler A. Kokjohn and Alex E. Roher


DOI: 10.2174/187152709787847315




Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle

, 8(2): 98 - 113

Vitaly Vasilevko and Elizabeth Head


DOI: 10.2174/187152709787847333




Alternative Aβ Immunotherapy Approaches for Alzheimers Disease

, 8(2): 114 - 127

Terrence Town


DOI: 10.2174/187152709787847306




Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy

, 8(2): 128 - 143

Anahit Ghochikyan


DOI: 10.2174/187152709787847298




Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention

, 8(2): 144 - 159

Rawan Tarawneh and David M. Holtzman


DOI: 10.2174/187152709787847324




AD Vaccines: Conclusions and Future Directions

, 8(2): 160 - 166

Thomas Wisniewski


DOI: 10.2174/187152709787847289




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science